PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clover Biopharmaceuticals, Chengdu, China.\', \'Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.\', \'Public Health Clinical Center of Chengdu, Chengdu, China.\', \'Division of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, China.\', \'Department of Pathology, Chengdu Fifth People\'s Hospital, Chengdu, China.\', \'Clover Biopharmaceuticals, Chengdu, China. liang.peng@cloverbiopharma.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-21634-1
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 33649323
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all